Outcomes of Venoplasty with Stent Placement for Chronic Thrombosis of the Iliac and Femoral Veins: Single-Center Experience

被引:65
作者
Kurklinsky, Andrew K. [3 ]
Bjarnason, Haraldur [1 ,2 ]
Friese, Jeremy L. [1 ,2 ]
Wysokinski, Waldemar E. [3 ]
McBane, Robert D. [3 ]
Misselt, Andrew [5 ]
Moller, Sigridur Margret [6 ]
Gloviczki, Peter [4 ]
机构
[1] Mayo Clin, Div Vasc Intervent Radiol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[3] Mayo Clin, Div Cardiovasc Med, Rochester, MN 55905 USA
[4] Mayo Clin, Div Vasc & Endovasc Surg, Rochester, MN 55905 USA
[5] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA
[6] Univ Iceland, Dept Radiol, Reykjavik, Iceland
基金
美国国家卫生研究院;
关键词
QUALITY-OF-LIFE; CATHETER-DIRECTED THROMBOLYSIS; DEEP VENOUS THROMBOSIS; POSTTHROMBOTIC SYNDROME; CONSENSUS STATEMENT; CONTROLLED-TRIAL; DISEASE; OBSTRUCTION; REVISION; THERAPY;
D O I
10.1016/j.jvir.2012.04.019
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To assess retrospectively 30-day, 1-year, and 3-year patency of chronically occluded iliofemoral venous thrombotic lesions treated with stent placement in a case series from a single institution. Materials and Methods: Records of 189 consecutive patients treated by interventional radiology for iliofemoral venous occlusions between March 1, 2003, and December 1, 2008, were retrospectively reviewed. A total of 89 patients (27 men; median age, 46.2 y) with chronic iliac or iliofemoral deep vein thrombosis without involvement of the inferior vena cava met criteria for analysis. Results: All patients (91 limbs) successfully underwent placement of venous self-expanding stents. Patency rate at discharge was 100%. Following the index procedure, mean pressure gradient across the lesion decreased from 5.63 mm Hg (95% CI, 3.51-7.75) to 0.71 mm Hg (95% CI, 0.08-1.34; P < .0001). There were no bleeding complications. Median follow-up was 11.3 months (range, 0.8-72.4 mo). Follow-up at 30 days demonstrated 90 of 91 limbs to be patent. Primary patency rates of treated limbs at 1 and 3 years were 81% and 71%, respectively. Primary patency was lost in 17 cases (19.1%); interventions to maintain or restore stent patency were performed in 13 cases (14.6%). Primary assisted limb patency rates at 1 and 3 years were 94% and 90%, respectively; secondary patency rate was 95%. Conclusions: Angioplasty with stent placement for treatment of chronically thrombosed iliofemoral veins is a low-risk procedure with acceptable patency rates for as long as 3 years. The outcomes in patients treated in a quaternary referral center are similar to those reported by other centers.
引用
收藏
页码:1009 / 1015
页数:7
相关论文
共 18 条
[1]   Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life [J].
Comerota, AJ ;
Throm, RC ;
Mathias, SD ;
Haughton, S ;
Mewissen, M .
JOURNAL OF VASCULAR SURGERY, 2000, 32 (01) :130-137
[2]   Venous claudication in iliofemoral thrombosis - Long-term effects on venous hemodynamics, clinical status, and quality of life [J].
Delis, KT ;
Bountouroglou, D ;
Mansfield, AO .
ANNALS OF SURGERY, 2004, 239 (01) :118-126
[3]   Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? [J].
Douketis, JD ;
Crowther, MA ;
Foster, GA ;
Ginsberg, JS .
AMERICAN JOURNAL OF MEDICINE, 2001, 110 (07) :515-519
[4]   Revision of the CEAP classification for chronic venous disorders:: Consensus statement [J].
Eklöf, B ;
Rutherford, RB ;
Bergan, JJ ;
Carpentier, PH ;
Gloviczki, P ;
Kistner, RL ;
Meissner, MH ;
Moneta, GL ;
Myers, K ;
Padberg, FT ;
Perrin, M ;
Ruckley, CV ;
Smith, PC ;
Wakefield, TW .
JOURNAL OF VASCULAR SURGERY, 2004, 40 (06) :1248-1252
[5]   Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency [J].
Enden, T. ;
Klow, N. -E. ;
Sandvik, L. ;
Slagsvold, C. -E. ;
Ghanima, W. ;
Hafsahl, G. ;
Holme, P. A. ;
Holmen, L. O. ;
Njaastad, A. M. ;
Sandbaek, G. ;
Sandset, P. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) :1268-1275
[6]   Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease [J].
Hartung, O ;
Otero, A ;
Boufi, M ;
De Caridi, G ;
Barthelemy, P ;
Juhan, C ;
Alimi, YS .
JOURNAL OF VASCULAR SURGERY, 2005, 42 (06) :1138-1144
[7]   Determinants of health-related quality of life during the 2 years following deep vein thrombosis [J].
Kahn, S. R. ;
Shbaklo, H. ;
Lamping, D. L. ;
Holcroft, C. A. ;
Shrier, I. ;
Miron, M. J. ;
Roussin, A. ;
Desmarais, S. ;
Joyal, F. ;
Kassis, J. ;
Solymoss, S. ;
Desjardins, L. ;
Johri, M. ;
Ginsberg, J. S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (07) :1105-1112
[8]   Antithrombotic therapy for venous thromboembolic disease [J].
Kearon, Clive ;
Kahn, Susan R. ;
Agnelli, Giancarlo ;
Goldhaber, Samuel ;
Raskob, Gary E. ;
Comerota, Anthony J. .
CHEST, 2008, 133 (06) :454S-545S
[9]  
Neglén P, 2000, J ENDOVASC THER, V7, P79, DOI 10.1583/1545-1550(2000)007<0079:BDASOC>2.3.CO
[10]  
2